Verition Fund Management’s Replimune Group REPL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-15,761
Closed -$146K 3964
2025
Q2
$146K Buy
+15,761
New +$138K ﹤0.01% 3434
2025
Q1
Sell
-23,328
Closed -$283K 3653
2024
Q4
$283K Sell
23,328
-11,620
-33% -$141K ﹤0.01% 2805
2024
Q3
$383K Sell
34,948
-33,377
-49% -$339K ﹤0.01% 2491
2024
Q2
$615K Buy
68,325
+51,987
+318% +$362K ﹤0.01% 1944
2024
Q1
$133K Buy
+16,338
New +$134K ﹤0.01% 2551
2023
Q4
Sell
-299,217
Closed -$5.12M 2624
2023
Q3
$5.12M Buy
+299,217
New +$5.88M 0.06% 425

Other funds holding REPL

Verition Fund Management's REPL Position: Q3 2025 in Review

Verition Fund Management sold out of Replimune Group (REPL) in Q3 2025, closing a stake of 15,761 shares — an estimated $146K sold.

Verition Fund Management first reported a position in REPL in Q3 2023 and held it in 6 quarters. The position peaked at $5.12M in Q3 2023. 163 funds tracked by Wall St. Rank hold REPL as of Q3 2025.

  • Verition Fund Management reported no remaining Replimune Group position as of Q3 2025 after selling out during the quarter.
  • Verition Fund Management sold 15,761 Replimune Group shares in Q3 2025, an estimated $146K.
  • Verition Fund Management first reported a position in Replimune Group in Q3 2023 and held it in 6 quarters.
  • Verition Fund Management's Replimune Group position peaked at $5.12M in Q3 2023.
  • 163 funds tracked by Wall St. Rank held Replimune Group as of Q3 2025.

Based on Verition Fund Management's 13F filing for Q3 2025, filed 14 Nov 2025.